Title Category Credit Event date Costsort descending
Living-Donor Liver Transplant for Patients with Liver Cancer
  • Disease Management
  • Managed care
  • Oncology
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • ASWB - Social Workers
$0.00 Activity descriptionLiving-donor liver transplants are life-saving treatments that can greatly decrease transplant waitlist times for recipients and allow donors to meaningfully contribute to others’ lives.
Health Disparities in Obesity
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • Attendance - General Attendance
  • CDR - Dietitians
05/03/2022 $0.00 These materials are intended only for those that attend the live activity on May 3, 2022.
Systemic Mastocytosis: Diagnostic and Therapeutic Updates
  • Disease Management
  • AAPC - Coders
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
06/14/2022 $0.00 Activity descriptionSystemic mastocytosis (SM) is often called “the great imitator.” Its symptoms are frequently complex and can mimic those of several other disorders, including those of immunologic, neurologic, dermatologic and endocrine etiologies. Individuals can suffer for years before assessments correctly reveal the presence of this disease due to its relative rarity and difficult diagnosis. 
The Diagnostic Odyssey for Individuals With Rare Diseases: Pompe Disease and Other Lysosomal Storage Diseases
  • Disease Management
  • Health Equity
  • AAPC - Coders
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • ASWB - Social Workers
08/09/2022 $0.00 Activity descriptionA disease is considered “rare” if it affects fewer than 200,000 individuals in the US. Uncovering the genetic roots of rare diseases and using those insights to develop new treatments is an ongoing process. Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. LSDs are characterized by an abnormal build-up of various materials in the body’s cells because of enzyme deficiencies and may affect different parts of the body.